Author

Kathy Hirst

Institution: University of Missouri

Observed institution: University of Missouri

OpenAlex ID: A5113070404

Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes

2022 · Xueya Zhou, Pamela Feliciano, et al. · Nature Genetics · 453

Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder

2023 · David Q. Beversdorf, Bradley Ferguson, et al. · Psychopharmacology · 24

Brief Report: A Double-Blind, Placebo-Controlled, Crossover, Proof-of-Concept Study of Minocycline in Autism Spectrum Disorder

2023 · Craig A. Erickson, Rebecca C. Shaffer, et al. · Journal of Autism and Developmental Disorders · 8

Cardiac Autonomic Measures Predict Clinician-Rated Anxiety and Behavioral Response to Propranolol in Autistic Children and Young Adults

2025 · Carrina Appling, Nanan Nuraini, et al. · Journal of Personalized Medicine · 4

A Pilot Feasibility Study Assessing the Combined Effects of Early Behavioral Intervention and Propranolol on Autism Spectrum Disorder (ASD)

2023 · Kathy Hirst, Rachel M. Zamzow, et al. · Children · 2

Psychophysiological Markers Predict the Effect of Propranolol on Conversational Reciprocity in Autism Spectrum Disorder (P9-5.002)

2022 · David Beversdorf, Bradley Ferguson, et al. · Neurology

Open Label Extension Findings for a Trial of Propranolol in Autism Spectrum Disorder (4533)

2021 · David Beversdorf, Bradley Ferguson, et al. · Neurology

Preliminary Report of Open Label Extension of Trial of Propranolol in Autism Spectrum Disorder (1614)

2020 · David Beversdorf, Bradley Ferguson, et al. · Neurology

Works count: 8

Citation count: 491

H-index: 4

I10-index: 2